Niranjan G. Kotla - Publications

Surface modified cationic PLGA microparticles as long-acting injectable carriers for intra-articular small molecule drug delivery.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: September 18, 2023

Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines.

Journal: Vaccines

Published: February 20, 2023

Hyaluronic Acid-Based Bioconjugate Systems, Scaffolds, and Their Therapeutic Potential.

Journal: Advanced healthcare materials

Published: November 29, 2022

IBD disease-modifying therapies: insights from emerging therapeutics.

Journal: Trends in molecular medicine

Published: September 25, 2022

Polyester-based long acting injectables: Advancements in molecular dynamics simulation and technological insights.

Journal: Drug discovery today

Published: August 11, 2022

Quercetin conjugated fluorescent nitrogen-doped carbon dots for targeted cancer therapy application.

Journal: Soft matter

Published: July 21, 2022

Modulation of Gut Barrier Functions in Ulcerative Colitis by Hyaluronic Acid System.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 24, 2021

Recent advances and prospects of hyaluronan as a multifunctional therapeutic system.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 06, 2021

Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease.

Journal: Biomaterials

Published: March 01, 2021

A high molecular weight hyaluronic acid biphasic dispersion as potential therapeutics for interstitial cystitis.

Journal: Journal of biomedical materials research. Part B, Applied biomaterials

Published: May 11, 2020

Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections.

Journal: Nano today

Published: May 06, 2020

Corrigendum to "A theranostic nanocomposite system based on iron oxide-drug nanocages for targeted magnetic field responsive chemotherapy" [Nanomedicine 14(5) (2018) 1643-1654].

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: March 31, 2020